Life Science REIT reported a 6.9% fall in EPRA net tangible assets (NTA) in annual results for 2024, laying bare the company’s struggles that led to its board launching a strategic review and putting it up for sale. EPRA NTA at the end of 2024 was 74.4p, down from 79.9p at the end of 2023, … Continue reading Life Science REIT’s struggles laid bare in annual results